Iminosugar Glucosidase Inhibitors Reduce Hepatic Inflammation in Hepatitis A Virus-Infected Ifnar1 −/− Mice

Authors:

Abstract
Hepatitis A virus (HAV) is a common cause of viral hepatitis. Iminosugar compounds block its replication in cultured cells by inhibiting the synthesis of gangliosides required for HAV cell entry but have not been tested for their ability to prevent or treat hepatitis A in vivo .
Funding Information
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (R01-AI103083)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (R01-AI131685)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (R01-AI150095)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK123499)

This publication has 37 references indexed in Scilit: